17-beta-hydroxysteroid dehydrogenase type 6
| GO Term | Evidence Code | Reference |
|---|---|---|
| steroid metabolic process |
|
|
| retinol metabolic process | ||
| brexanolone catabolic process | ||
| brexanolone catabolic process | ||
| brexanolone catabolic process |
| GO Term | Evidence Code | Reference |
|---|---|---|
| early endosome membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| estradiol 17-beta-dehydrogenase [NAD(P)+] activity | ||
| estradiol 17-beta-dehydrogenase [NAD(P)+] activity | ||
| estradiol 17-beta-dehydrogenase [NAD(P)+] activity | ||
| all-trans-retinol dehydrogenase (NAD+) activity | ||
| all-trans-retinol dehydrogenase (NAD+) activity |
| Pathway Name | Organism |
|---|---|
| The canonical retinoid cycle in rods (twilight vision) | Mus musculus |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026